What does fact checked mean?
At Healthfully, we strive to deliver objective content that is accurate and up-to-date. Our team periodically reviews articles in order to ensure content quality. The sources cited below consist of evidence from peer-reviewed journals, prominent medical organizations, academic associations, and government data.
- "Expert Opinion in Pharmacotherapy"; Male Androgenetic Alopecia; Rathnayake D, Sinclair R; June 2010
- "Expert Opinion in Pharmacotherapy"; Male Androgenetic Alopecia; Rathnayake D, Sinclair R; June 2010
- MayoClinic.com: Hair loss
The information contained on this site is for informational purposes only, and should not be used as a substitute for the advice of a professional health care provider. Please check with the appropriate physician regarding health questions and concerns. Although we strive to deliver accurate and up-to-date information, no guarantee to that effect is made.
Hair Loss & Low Testosterone
Hair loss may occur through several mechanisms, however the only form related to testosterone levels is known as androgenetic alopecia. A hereditary disorder characterized by thinning of scalp hair, androgenetic alopecia occurs in both men and women through an androgen mediated mechanism. While this syndrome is technically a low testosterone state, in fact the body is experiencing high androgen levels due to the mechanism of dihydrotestosterone (DHT), a metabolite of testosterone with potent androgenic effects.
Hair Physiology
In a healthy hair follicle, circulating DHT binds androgen receptors located on hair follicles. DHT has a potent effect on these receptors, directly inhibiting the growth of the hair follicle. This occurs in normal individuals, allowing accurate control of the hair growth cycle.
Hair Loss Pathogenesis
What Is a Natural DHT Blocker for a Woman's Scalp?
Learn More
Circulating testosterone is converted peripherally to DHT by the enzyme 5-alpha reductase. Patients with elevated 5-alpha reductase levels may develop a high DHT/low testosterone state. Pathologic hair loss occurs when the individual's DHT reaches levels at which the inhibitory effects outweigh the stimulatory forces on the hair follicle. Therefore, while low testosterone is associated with hair loss, the pathologic mechanism occurs via the elevated DHT levels. This results in progressively shorter, less pigmented hair production, which ultimately presents as hair thinning and loss.
- Circulating testosterone is converted peripherally to DHT by the enzyme 5-alpha reductase.
- Therefore, while low testosterone is associated with hair loss, the pathologic mechanism occurs via the elevated DHT levels.
Presentation and Progression
According to an article from “CURRENT Diagnosis and Treatment in Otolaryngology,” androgenic alopecia first presents in men with “bitemporal hairline recession followed by thinning of the vertex.” The progression involves further thinning of the vertex and the formation of a bald patch, which may enlarge and ultimately combine with the frontal receding hairline 1. Female hair loss typically presents with diffuse thinning of the frontal or parietal scalp, though a rim of hair along the frontal hairline is often maintained.
Expert Insight
Frontal Baldness Treatment
Learn More
Researchers at St. Vincent’s Hospital Melbourne Department of Dermatology reviewed the advancements in treatment of androgenic alopecia. The therapy has approached the treatment of this disease based on our knowledge of its pathogenesis. In the article, Dr. Rathnayake reports on inhibitors which target 5-alpha reductase, thus reducing the overproduction of DHT in patients. As of November 2010, these drugs are in phase III trials.
- Researchers at St. Vincent’s Hospital Melbourne Department of Dermatology reviewed the advancements in treatment of androgenic alopecia.
- In the article, Dr. Rathnayake reports on inhibitors which target 5-alpha reductase, thus reducing the overproduction of DHT in patients.
Prevention and Treatment
State-of-the-art treatments for hair loss related to decreased testosterone include topical minoxidil and oral finasteride. These treatments are FDA approved for the treatment of androgenic alopecia. While rather effective in reducing the progression of the disease, these treatments allow only partial re-growth of hair that has already been lost.
Related Articles
References
- "CURRENT Diagnosis and Treatment in Otolaryngology"; Min S. Ahn MD; 2010
- "Expert Opinion in Pharmacotherapy"; Male Androgenetic Alopecia; Rathnayake D, Sinclair R; June 2010
- MayoClinic.com: Hair loss
- Futterweit, W. (October 2011). A Patient's Guide: Management of Hair Loss in Polycystic Ovary Syndrome.ObGyn.net.
- Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Womens Health. 2013;5:541–556. Published 2013 Aug 29. doi:10.2147/IJWH.S49337
- Fabbrocini G, Cantelli M, Masarà A, Annunziata MC, Marasca C, Cacciapuoti S. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol. 2018;4(4):203–211. Published 2018 Jun 19. doi:10.1016/j.ijwd.2018.05.001
- Brough KR, Torgerson RR. Hormonal therapy in female pattern hair loss. Int J Womens Dermatol. 2017;3(1):53–57. Published 2017 Feb 24. doi:10.1016/j.ijwd.2017.01.001
- Choi FD, Juhasz MLW, Atanaskova Mesinkovska N. Topical ketoconazole: a systematic review of current dermatological applications and future developments. J Dermatolog Treat. 2019 Dec;30(8):760-771. doi: 10.1080/09546634.2019.1573309. Epub 2019 Feb 14. PMID: 30668185.
- Hegde P, Relhan V, Sahoo B, Garg VK. A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of platelet-rich plasma in patchy alopecia areata of the scalp. Dermatol Ther. 2020 Oct 9:e14388. doi: 10.1111/dth.14388. Epub ahead of print. PMID: 33034942.
- Futterweit, W. (October 2011). A Patient's Guide: Management of Hair Loss in Polycystic Ovary Syndrome.ObGyn.net.
Writer Bio
I have completed the first two years of medical school, during which time I have developed expertise in writing on medical and science topics for eHow and Livestrong. My blog, cAMPScience.org, has recently been approved at DMS for "Blogger" status, which will allow me to continue to develop my brand with this organization. I will provide high quality articles, using only the best sources in medical and science research.